Skip to main content
. 2021 Jan 6;10(1):82. doi: 10.3390/cells10010082

Table 2.

Proportion of Sysmex morphological parameters in patients: with positive COVID-19 test—group A, control group (HC)—group B and the group with other virus infections with negative COVID-19 test—group C. Data expressed as median (Q1–Q3).

Sysmex Parameters
[Median (Q1–Q3)]		 A.
COVID-19(+)
n = 20		 B.
HC
n = 20		 C.
COVID-19(−)
Viruses
n = 20		 * p < 0.05
A-B-C
Anova
Kruskal-Wallis		 * p < 0.05
in Groups
Post-Hoc
  • -

    WBC [103/µL]

 4.25 (3.59–6.72) 6.08 (5.06–8.02) 6.72 (4.14–9.34)
  • -

    NEUTROPHILS [103/µL]

 2.84 (2.20–3.38) 3.44 (3.12–4,70) 3.51 (2.18–4.90)
  • -

    LYMPHOCYTES [103/µL]

 0.85 (0.69–1.56) 1.72 (1.52–2.32) 1.95 (1.25–2.93) * p = 0.0250 A-B, A-C
  • -

    MONOCYTES [103/µL]

 0.36 (0.26–0.64) 0.56 (0.42–0.69) 0.57 (0.36–0.69)
  • -

    EOSINOPHILS [103/µL]

 0.05 (0.00–0.08) 0.18 (0.07–0.26) 0.10 (0.05–0.16) * p = 0.0038 A-B
  • -

    BASOPHILS [103/µL]

 0.02 (0.02–0.04) 0.04 (0.02–0.05) 0.04 (0.02–0.06) * p = 0.0003 A-B
  • -

    IG [103/µL]

 0.02 (0.01–0.09) 0.01 (0.01–0.02) 0.02 (0.01–0.04)
  • -

    PLT [103/µL]

 196.00 (177–290) 261.50 (230–287) 226.50 (190–286)
  • -

    RE-LYMP [109/L]

 0.05 (0.04–0.09) 0.08 (0.05–0.10) 0.21 (0.13–0.37)
  • -

    RE-LYMP [%]

 5.45 (2.80–8.20) 4.20 (3.10–5.00) 11.05 (7.75–25.2) * <0.0001 A-C, B-C

Abbreviations: HC, healthy control; IG, Immature Granulocyte count; PLT, platelets; RE-LYMP, reactive lymphocytes; WBC, white blood cell count, * p < 0.05 statistically significant.